The Latest
-
Pfizer, BioNTech’s coronavirus vaccine candidates get FDA’s ‘fast track’ status
-
Here’s What We Learnt About The CEO Pay At NVIDIA Corporation (NASDAQ:NVDA)
-
Disney World Cautiously Reopens; Analyst Optimistic On Outlook
-
Moderna’s Newest Bull Sees Over $5 Billion in Vaccine Sales